beta-D-Galp-(1->3)-beta-D-GalpNAc-(1->4)-D-Glcp-(1<->1')-Cer

Term ID

CHEBI:61797

Synonyms

AGM1
beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-D-Glc-(1<->1')-Cer
beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->4)-D-glucopyranosylceramide
beta-D-galactosyl-(1->3)-2-acetamido-2-deoxy-beta-D-galactosyl-(1->4)-D-glucosylceramide
beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-D-glucopyranosylceramide
N-[(2S,3R,4E)-1-{[beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->4)-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]acetamide

Definition

A glycotriaosylceramide having beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-D-glucose as the glycotriaosyl component.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: glycotriaosylceramide

glycotriaosylceramide Show first 5 Terms

Phenotype

Phenotype resulting from beta-D-Galp-(1->3)-beta-D-GalpNAc-(1->4)-D-Glcp-(1<->1')-Cer

Phenotype where environments contain beta-D-Galp-(1->3)-beta-D-GalpNAc-(1->4)-D-Glcp-(1<->1')-Cer

Phenotype modified by environments containing beta-D-Galp-(1->3)-beta-D-GalpNAc-(1->4)-D-Glcp-(1<->1')-Cer

Human Disease Model